Innovation Hub / Podcasts
Weekly News Roundup - RSV Breakthrough Data, Psychedelic Approvals on the Horizon, and Major FDA Policy Shifts
February 20, 2026
This week's tHEORetically Speaking News Roundup covers new real-world data showing Sanofi's Beyfortus delivering multi-season protection against RSV hospitalizations, Compass Pathways' positive Phase 3 results for its psilocybin therapy in treatment-resistant depression, and the FDA's move toward a single-trial approval standard. We also explore stabilizing telehealth utilization trends and new FDA scrutiny of SSRI and RSV antibody safety.
Weekly News Roundup - PhRMA Leadership Transition, The ICHRA Shift, and MDUFA VI Preliminary Deal
Talking Real Science with Stella Goulopoulou
Talking Real Science with Yelena Akelina
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments
Talking Real Science with Licy Yanes Cardozo
Industry Insights with Bas Trietsch and STEMCELL Technologies
Talking Real Science with Helen Collins
Talking Real Science with Rachel Buckley
Talking Real Science with Meaghan Loy on Rare Disease Day